ZBIO

Zenas BioPharma, Inc. - Common Stock (ZBIO)

About Zenas BioPharma, Inc. - Common Stock (ZBIO)

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company. The firm is mainly engaged in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.

Details

Daily high

$10.49

Daily low

$9.60

Price at open

$9.95

52 Week High

$26.25

52 Week Low

$5.83

Market cap

418.7M

Dividend yield

0.00%

Volume

79,751

Avg. volume

223,793

P/E ratio

-2.57

Zenas BioPharma, Inc. - Common Stock News